Get the Daily Brief
Latest Biotech News
Advanced Multiplexing Maps Kidney Immune Disease with Precision
Researchers have introduced PathoPlex, a novel multiplexing imaging platform that enables high-dimensional, spatially-resolved analysis of immune-mediated kidney diseases. This breakthrough...
Single-Cell Atlas Illuminates Immune Drivers in Type 2 Diabetes
A pioneering single-cell atlas study has identified key chemokines linked to immune dysfunction in type 2 diabetes, shedding light on its complex pathophysiology beyond metabolic factors. The...
Engineered Bacteria Usher New Era in Animal-Free Dairy Proteins
Scientists have successfully bioengineered Escherichia coli to produce authentic milk proteins vital for cheese and yogurt manufacture without animal inputs. This innovation paves the way for...
Additive Manufacturing Innovates Solid Oxide Cell Design
Researchers unveiled a novel additive manufacturing approach to produce monolithic gyroidal solid oxide cells (SOCs) that significantly improve efficiency and durability. This three-dimensional...
Machine Learning Deciphers Sorghum’s Genetic Mold Resistance
Advanced machine learning techniques have deciphered the complex genetic basis underlying sorghum’s resistance to grain mold, a significant fungal threat to this key cereal crop. This integrative...
Xeltis Reports Positive Clinical Results for Bioengineered Heart Conduit
Xeltis announced favorable outcomes from its EU clinical trial evaluating Xabg, an innovative coronary artery bypass graft made from bioresorbable materials that regenerate into living tissue....
HHS Notice on Federal Benefits Provokes Legal Pushback
A new HHS federal notice restricting benefit access for undocumented and lawfully present immigrants has triggered criticism from advocacy groups and legal challenges. Democratic attorneys general...
Sarepta Gene Therapy Crisis: FDA Moves to Halt Duchenne Treatment
Sarepta Therapeutics is facing a major regulatory challenge as the FDA prepares to request a halt on shipments of its Elevidys gene therapy for Duchenne muscular dystrophy following multiple...
Scipher Medicine Shifts Toward Data-Driven Precision Medicine
Scipher Medicine, traditionally focused on diagnostics for rheumatoid arthritis, is pivoting toward leveraging its extensive transcriptomic datasets to drive precision medicine beyond oncology....
FDA Regulatory Setbacks and Clinical Updates in Biopharma
Recent regulatory and clinical developments include the FDA advisory committee voting against approval of Otsuka’s Rexulti-Zoloft combo for PTSD due to insufficient Phase 3 data, and the FDA...
Gene Therapy Safety Under Scrutiny: Lessons From Sarepta Deaths
The recent deaths in Sarepta’s gene therapy trials have reignited debates reminiscent of the Jesse Gelsinger incident about safety oversight in gene therapy. Industry experts and patient advocates...
Boston Area Expands Biomanufacturing Capacity with GenesisM Facility
GenesisM has initiated construction of a 154,000-square-foot, Class A biomanufacturing facility in Bedford, MA, reinforcing Boston's status as a leading biopharma cluster. The multi-tenant suite...
Neuralink Valued at $9 Billion Despite Small Disadvantaged Business Filing
Neuralink, Elon Musk’s brain-computer interface company, recently filed as a 'small disadvantaged business' with the U.S. Small Business Administration, a status that can offer federal procurement...
Innovative Biotechnology: Engineered Bacteria Create Milk Proteins for Vegan Products
Scientists have engineered Escherichia coli bacteria to produce key milk proteins essential for authentic cheese and yogurt, eliminating the need for cows in dairy production. This breakthrough...
Advanced Multiplexing Reveals Kidney Disease Mechanisms
Researchers have introduced PathoPlex, a multiplex pathology technology enabling spatially resolved, high-dimensional imaging to map immune-mediated kidney disease at cellular and molecular...
Machine Learning Deciphers Sorghum Mold Resistance Genetics
In an effort to safeguard global food security, researchers employed machine learning techniques to untangle the complex genetic basis of sorghum grain mold resistance. This work addresses a...
Multiomic Biomarker Research Gets Boost with €2.5M Grant in Vienna
The Medical University of Vienna's Core Facilities secured €2.5 million from the Austrian Research Promotion Agency to advance multiomics-based biomarker discovery and validation. The funding...
Sarepta's Gene Therapy Deaths and FDA Confrontation
Sarepta Therapeutics faces a crisis following the deaths of three patients linked to its gene therapies for Duchenne muscular dystrophy and limb-girdle muscular dystrophy. The fatalities, caused...
Scipher Medicine Expands into Precision Medicine
Scipher Medicine is pivoting from solely providing molecular diagnostics for rheumatoid arthritis to advancing data-driven precision medicine development across non-oncology diseases. Under CEO...
Biopharma Financing Trends and Facility Expansion
Biopharma financing remains robust in 2025 with notable increases in seed and Series A investments despite fewer contributing companies. GenesisM has initiated construction of a 154,000 sq ft...